FBXW7/Cdc4 Antibody Blocking Peptide

Name: FBXW7/Cdc4 Antibody Blocking Peptide
Brand: Novus Biologicals
SKU: NBP1-59631PEP

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-59631PEP

Submit a review

Product Datasheet / COA

100% Guarantee

Product Specifications
Preparation & Storage
Background
Product Documents
Specific Notices

Key Product Details

Source

Synthetic

Conjugate

Unconjugated

Applications

Antibody Competition

View all FBXW7/Cdc4 Proteins and Enzymes »

Product Specifications

Description

A human FBXW7/Cdc4 blocking peptide.

Source: Synthetic

Amino Acid Sequence within the following region: KTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLD (Accession #: Q969H0).

Purity

N/A

Predicted Molecular Mass

77 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Application Notes

This peptide is useful as a blocking peptide for NBP1-59631. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochemistry under proper experimental settings. Use of this product in any other assay has not yet been tested. For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NBP1-59631PEP

Formulation	Lyophilized
Preservative	No Preservative
Concentration	Lyoph
Reconstitution	Reconstitute with 100ul of sterile PBS to a final concentration of 1 mg/ml.
Shipping	The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage	Store at -20C. Avoid freeze-thaw cycles.

Background: FBXW7/Cdc4

MTR is the enzyme 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G. MTR encodes the enzyme 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G. Sequence Note: This RefSeq record was created from transcript and genomic sequence data because no single transcript was available for the full length of the gene. The extent of this transcript is supported by transcript alignments. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

Long Name

F-box and WD Repeat Domain Containing 7

Alternate Names

AGO, Archipelago Homolog, Cdc4, FBW6, Fbw7, FBX30, FBXO30, FBXW6, SCF(Fbw7), SEL10

Gene Symbol

FBXW7

Additional FBXW7/Cdc4 Products

Product Documents for FBXW7/Cdc4 Antibody Blocking Peptide

Product Datasheets

Download Product Datasheets

COA

Product Specific Notices for FBXW7/Cdc4 Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Citations
Reviews